Skip to content

Frank, Rimerman Advisors LLC: UMC position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Frank, Rimerman Advisors LLC on UMC, newest first. How the timeline and the estimate are built.

Frank, Rimerman Advisors LLC held 124,326 UMC shares at 2026-06-30 per its 13F-HR filed 2026-07-27.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 124,326 shares
    Change vs previous 13F +1,293 shares

    0.19% of the 13F portfolio, value $3,382,910.

    13F-HR 0001172661-26-002823 filed by Frank, Rimerman Advisors LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 123,033 shares
    Change vs previous 13F 0 shares

    0.07% of the 13F portfolio, value $1,104,836.

    13F-HR 0001172661-26-001573 filed by Frank, Rimerman Advisors LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 123,033 shares
    Change vs previous 13F +102,259 shares

    0.06% of the 13F portfolio, value $967,039.

    13F-HR 0001172661-26-000203 filed by Frank, Rimerman Advisors LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 20,774 shares
    Change vs previous 13F -41,308 shares

    0.01% of the 13F portfolio, value $157,467.

    13F-HR 0001172661-25-004566 filed by Frank, Rimerman Advisors LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 62,082 shares
    Change vs previous 13F not available

    0.03% of the 13F portfolio, value $474,927.

    13F-HR 0001172661-25-002995 filed by Frank, Rimerman Advisors LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).